ABL Texcell Diagnostics signs letter of intent to acquire Vela Diagnostics assets
ABL Texcell Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore and Vela Diagnostics USA. The company aims to consolidate an integrated international platform covering EMEA, Asia-Pacific, and the United States.